Moreover, the sirtuin inhibitor tenovin-6 was demonstrated to suppress autophagy in chronic lymphocytic leukemia (CLL) cells as evidenced by increased expression of autophagy-lysosomal pathway genes and the autophagic markers LC3-II and p62 [220]. The gene discussed is SQSTM1; the disease is B-cell chronic lymphocytic leukemia.